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Abstract
In 2007, the Centers for Disease Control and Prevention (CDC) reported that Human adenovirus type 14 (HAdV-14) infected
106 military personnel and was responsible for the death of one U.S. soldier at Lackland Air Force Base in Texas.
Identification of the responsible adenovirus, which had not previously been seen in North America and for which rapid
diagnostic tools were unavailable, required retrospective analysis at reference laboratories. Initial quarantine measures were
also reliant on relatively slow traditional PCR analysis at other locations. To address this problem, we developed a real-time
PCR assay that detects a 225 base pair sequence in the HAdV-14a hexon gene. Fifty-one oropharyngeal swab specimens
from the Naval Health Research Center, San Diego, CA and Advanced Diagnostic Laboratory, Lackland AFB, TX were used to
validate the new assay. The described assay detected eight of eight and 19 of 19 confirmed HAdV-14a clinical isolates in two
separate cohorts from respiratory disease outbreaks. The real-time PCR assay had a wide dynamic range, detecting from 10
2
to 10
7 copies of genomic DNA per reaction. The assay did not cross-react with other adenoviruses, influenza, respiratory
syncytial virus, or common respiratory tract bacteria. The described assay is easy to use, sensitive and specific for HAdV-14a
in clinical throat swab specimens, and very rapid since turnaround time is less than four hours to obtain an answer.
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Introduction
Human adenoviruses (HAdVs) were the first respiratory viruses
to be isolated and characterized. They were initially isolated from
cultured adenoid tissue, within which these viruses may remain
viable in a quiescent and asymptomatic state [1]. HAdVs were
first identified as agents of disease among military trainees
suffering from epidemics of acute respiratory disease (ARD), in
the early 1950s [2]. Epidemiological studies confirmed and
continue to show that adenoviruses are the primary cause of ARD
epidemics among military recruits [3,4] and also a common cause
of both endemic and epidemic ARD among civilians. The diverse
human pathogens of the genus Mastadenovirus in the family
Adenoviridae are categorized into 53 types. These viruses have
been grouped into seven species (A–G), based on their
immunochemical responses, nucleic acid characteristics, hexon
and fiber protein characteristics, biological properties, and
phylogenetic relationships [5,6]. They are transmitted by the
fecal-oral route and the respiratory route and are associated with
acute respiratory disease (ARD), conjunctivitis, genitourinary
infections, and gastroenteritis [7].
Although basic military trainee sites can involve several types,
public health response measures at military facilities are weakened
because detection of ARD causing HAdVs is primarily accom-
plished by conventional PCR [8]. Primarily these infections are
caused by HAdV-4 and –7 [8]; although HAdV-3, -11, -14, and
-21 have also been detected at military bases and civilian settings
as well [8,9,10]. Unfortunately, in February 2007, when a HAdV-
14 febrile respiratory disease outbreak occurred in basic military
trainees at Lackland Air Force Base [11], it took nearly three
months to determine which genotype was responsible for infection
[11]. Because adenovirus types vary in terms of clinical
manifestation, outbreak severity, and susceptibility to developed
vaccines, it is very useful to know which HAdV type is involved in
any specific case or outbreak. Since the initial HAdV-14 outbreak
in North America, it has been shown that the outbreak strain only
contains one deletion in the fiber gene (DK250–E251) which
differentiates it from the prototype deWit strain (HAdV-14p) and
has been provisionally named HAdV-14a [12].
The J.B.A.I.D.S. thermocycler was conceived and developed to
standardize biowarfare threat agent detection equipment to meet
the need within the Department of Defense to enhance protection
of U.S. military personnel in deployed locations. The software
used in the J.B.A.I.D.S. is similar to the software used in the
LightCycler 2.0. The thermocycler is a ruggedized and portable
biological agent identification system that is capable of simulta-
neously identifying multiple biological agents.
In this study we developed a reliable, rapid real-time PCR assay
that detects a 225 bp segment of the hexon gene of both the HAdV-
14p and -14a genomes on the J.B.A.I.D.S. and LightCycler 2.0
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preparations of isolated virus and original clinical throat swabs from
recognized HAdV-14 outbreaks in military populations.
Results
Detection of clinical isolates
Our real-time J.B.A.I.D.S. PCR assay detects a unique 225 bp
segment in the hexon gene of the HAdV-14p and -14a genomes
(Fig. 1). This region is unique since there is little sequence
homology in this region. The detection of HAdV-14a by
conventional and real-time LC PCR of the clinical isolates is
summarized in Table 1. We tested 27 HAdV-14-positive clinical
samples from the Naval Health Research Center (NHRC) and the
Advanced Diagnostic Laboratory (ADL) as well as 24 HAdV-14-
negative clinical specimens from patients with ARD in similar
populations (Tables 1 and 2). These samples were scored negative
if no amplicon was acquired through conventional PCR for
HAdV-3, -4, -7, -11, -14, or –21. All of these samples were
correctly identified by the described assay. These results, generated
at two separate institutions, support appropriate sensitivity of the
assay and demonstrate that it does not generate false positive
results from human genomic sequence or common commensals
occurring in throat swabs (Tables 1 and 2). Therefore, our results
were 100% concordant with original results generated with well-
validated standard PCR and sequence-based assays [13].
Sensitivity of HAdV-14 assay
A standard curve was created using 10-fold dilutions with
genomic HAdV-14 DNA (10
2 to 10
7 genome copies per assay)
from the deWit strain (accession # AY803294) to allow
determination of the concentration of adenovirus in the clinical
samples (Fig. 2). The lower limit of detection for the assay was 100
genomic copies per reaction (Fig. 2). Linear regression of the CP
values and the quantity of genomic DNA revealed a negative
linearity (error =0.05 and a slope -3.76) corresponding to an
84.5% PCR efficiency. The dynamic range for the assay was 10
2
to 1.0610
7 HAdV-14 DNA genomic copies per PCR reaction.
This experiment was repeated twice and yielded similar results.
The viral load in analyzed throat swab samples varied from less
than 4610
5 to 2.1610
8 genomic copies per milliliter (Table 3).
Specificity of HAdV-14 assay
Because of the high degree of genetic similarity between the
HAdV types within species HAdV-B, we wanted to demonstrate
that our assay was specific to HAdV-14. The assay did not
generate amplicons from other adenovirus genotypes that cause
respiratory disease (Table 4). Furthermore, the assay was unable to
Figure 1. Alignment of species HAdV-B Hexon sequences which span the HAdV-14 primers and TaqMan probe. Note that the HAdV-
14a and HAdV-14p sequences are identical. The forward primer sequence is highlighted in green, the FAM/TAMRA probe is highlighted in aqua, and
the reverse primer is highlighted in red. Asterisks underneath sequences highlight identity in the species.
doi:10.1371/journal.pone.0007081.g001
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bacterial and/or viral agents known to cause respiratory disease
or to reside in the respiratory tract (Table 4).
Discussion
There are several studies describing adenovirus detection [14–
19]. However, there are no known type-specific real-time PCR
assays to detect HAdV-14a. This is the first study demonstrating a
sensitive and specific real-time PCR assay that detects HAdV-14
in clinical samples. Our assay detected a 225-bp amplicon in the
hexon gene of the HAdV-14 genome in samples from patients who
tested positive for HAdV-14 via conventional PCR.
In 2006 and 2007 HAdV-14 emerged as a significant contributor
toacuterespiratorydisease(ARD)and severepneumoniasinseveral
US cities and at military recruit training centers across the United
States [8,11,12,20]. HAdV-14a outbreaks can cause severe
pneumoniaandoccasional deathinpatients ofall ages,asevidenced
by the HAdV-14a outbreaks at Lackland AFB between February
and July of 2007 and the temporally associated outbreaks among
civilians in Oregon [11]. It is important to have diagnostic tools
readily available that can determine which adenovirus is causing a
particular outbreak. Although this assay works well on the
LightCycler 2.0, it was important that this assay also worked well
on the J.B.A.I.D.S. system since this platform is utilized at U.S.
military installationsinthe United Statesaswellasoverseas.Further
studies should be done to generate multiplex assays that detect all
common epidemic respiratory adenoviruses.
Interestingly, the viral loads for HAdV-14 that we detected in
uncultured clinical specimens were 1 to 3 logs below those seen in
our lab for other common types, including HAdV-3, -4, -7, and
–21 (data not shown). If the patient samples were acquired after
peak viremia, this could explain the lower viral loads. Another
possibility is that HAdV-14a may not be very effective at
replicating due to unique genetic characteristics. This offers
further purpose for the development of real-time assays, as these
assays are generally more sensitive than standard PCR assays or
rapid antigen tests [21,22]. Having the capability to quantitate
viral loads will be a valuable tool to further our understanding of
type-specific aspects of adenoviral disease.
Including nucleic acid extraction, this assay can be used to
determine whether or not a sample is positive or negative in less than
four hours. Furthermore, the material cost of each test is $2.16. This
real-time PCR assay demonstrated 100% concordance with the
conventional PCR assays [13] initially used to identify HAdV-14 in
these samples and did not generate any false negatives or false
positives. This assay provides quantitative data and does not cross
reactwithotherARD-causingadenoviruses.Thus,ifanotherHAdV-
14 outbreak occurs within the Department of Defense or within the
civilian community, similar to the outbreak at Lackland AFB, we will
have the tools available to rapidly detect HAdV-14 at low cost.
In conclusion, we generated a cost effective real-time PCR assay
optimized for the J.B.A.I.D.S. and LightCycler 2.0 platforms, and
demonstrated that this assay is sensitive and specific for HAdV-14.
If accredited as an in-house diagnostic test in labs serving affected
populations, this assay will be useful as a routine diagnostic tool for
HAdV-14 infection.
Materials & Methods
Clinical samples
Informed consent was obtained in writing. The IRB-approved
inclusion criteria of subjects enrolled at Lackland AFB were
individuals greater than 18 years of age who presented with upper
respiratory illness symptoms to the Wilford Hall Medical Center
Hospital or clinics and military trainees who were 18 years or older
at the time ofenrollmentwho presented torecruithealthclinicswith
URI symptoms or pneumonia. IRB-approved inclusion criteria for
consented subjects enrolled through the NHRC febrile respiratory
illness surveillance system were military recruits reporting for
medical care with respiratory symptoms and a fever of $38uC.
Samples collected through the NHRC program were oropharyn-
geal swabs resuspended in COPAN Viral Transport Medium
(VTM), and subsequently frozen at 280uC and transported on dry
ice for testing. Aliquots used in this study were subjected to one
freeze/thaw cycle in the process of aliquotting upon receipt at
NHRC, and one further freeze/thaw cycle when aliquotted for
shipment to Travis AFB. These samples were otherwise unpro-
cessed, collected, and transported under College of American
Pathologists (CAP) accredited diagnostic protocols.
Specimen processing
Nasal wash samples were collected in approximately 2 mls of
saline and nucleic acid extraction was performed at room
temperature prior to freezing of the remaining aliquots. From
each sample, 400 ml was aliquoted into 2 ml microcentrifuge tubes
for automated DNA extraction. Extractions were performed using
the MagNA Pure Compact Nucleic Acid Isolation Kit I (Roche
Diagnostics, Mannheim Germany, MagNA Pure Kit 03 730 964
001) with the MagNA Pure Compact instrument by Roche,
Table 1. Summary of Human adenovirus 14 detection by conventional and real-time PCR in clinical specimens from the NHRC.
Conventional PCR result from NHRC
J.B.A.I.D.S. real-time PCR for
Adenovirus 14
LightCycler real-time PCR for
Adenovirus 14
Positive Negative Positive Negative Positive Negative
HAdV-14 positive 19 0 19 0 19 0
HAdV-14 negative 0 20 0 20 0 20
doi:10.1371/journal.pone.0007081.t001
Table 2. Summary of Human adenovirus 14 detection by
conventional and real-time PCR in clinical specimens from the
ADL.
J.B.A.I.D.S. real-time
PCR for Adenovirus 14
Positive Negative
Conventional PCR result
from ADL
HAdV-14 positive 8 0
HAdV-14 negative 0 4
doi:10.1371/journal.pone.0007081.t002
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was programmed to extract a 400 ml sample and elute 200 mlo f
purified DNA (Ver. 1.0; software version 1.1 DNA_Bacteria
purification protocol) for nasal wash samples.
Throat swabs and cultured isolates were processed in a BSL-2
hood. Nucleic acid was extracted from 175 mL aliquots using the
MagNA Pure LC DNA Isolation Kit I (Roche, Indianapolis, IN,
USA) according to the manufacturers’ recommendations for the
MagNA Pure LC automated nucleic acid extraction system. The
following adenovirus strains were used as controls for reactivity with
our HAdV-14 assay: Adenovirus strains HAdV-14 (VR-15), -3 (VR-
3), -4 (VR-1572), -7 (VR-7), -11 (VR-12), -21 (VR-256), Haemoph-
ilus influenza, Influenza A virus (ATCC VR-96), Human rhinovirus
14 (ATCC VR-284), Human parainfluenza virus 2 (ATCC VR-92),
Human respiratory syncytial virus (ATCC VR-26), Chlamydophila
pneumonia (ATCC 53592), Escherichia Coli, Klebsiella pneumonia (ATCC
13883), Pseudomonas aeruginosa (ATCC 97), Mycoplasma pneumonia,a n d
Legionella Pneumophila (ATCC 33152) were acquired from the
American Type Culture Collection (ATCC; Manassas, VA, USA).
Conventional PCR testing
The primers used to amplify HAdV-14 by conventional PCR
were Ad14F 59-AAATGCTAATCTTGGACAGCAGTC-39 and
Ad14R 59- AGCCGTCCAGTGGAAAACAGTAGT-39. Reac-
tion mixtures for conventional PCR performed at the Naval
Health Research Center contained 1 mL of Q-Solution (QIAGEN),
1 mL PCR buffer (Promega, Madison, Wis.), 0.6 mM concentration
of each primer (Integrated DNA Technologies), 0.8 mM concen-
Figure 2. Sensitivity of Human adenovirus 14 detection by real-time J.B.A.I.D.S. PCR in a series of 10-fold dilutions of genomic
HAdV-14 DNA (10
2 to 10
7) per PCR reaction. (A) Amplification profile of real-time J.B.A.I.D.S. PCR. (B) Linear regression of the standard curve.
doi:10.1371/journal.pone.0007081.g002
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concentration of MgCl2 (Promega), 1.25 U of Taq polymerase
(Promega), and 2 mLs of extracted sample in 25-mL aqueous
reactions. Reaction conditions were as follows: initial denaturation
at 95uC for 5 min, followed by 35 cycles of denaturation at 95uC for
1 min, annealing at 53uC for 1 min, and extension at 72uC for
1 min.Cyclingconditionsincludeda10 minfinalextensionat72uC
and a final hold at 4uC.
Quantitative real-time PCR
The primers used to generate the HAdV-14 amplicon were
prAd14-hex2F, 59-GGGTTGAAACTACTGAAGAACG-39 and
prAd14-hex2R, 59-CATCTGTATCAGTCCACGATT-39. The
TaqMan probe used to detect the hexon gene have the following
sequence: Ad14-TaqMan1, [6,FAM]AGCTACATACACTTT-
TGGCAATGCC[Tamra,Q]. Experiments were performed on a
Joint Biological Agent Identification and Diagnostic System
(J.B.A.I.D.S) and the LightCycler 2.0 (Roche). The J.B.A.I.D.S.
thermocycler was conceived and developed to rapidly identify
biological warfare agents and other pathogens of concern for the
U.S. Military. For real-time J.B.A.I.D.S. PCR, cycling was carried
out in a J.B.A.I.D.S. real-time thermocycler (Idaho Technologies,
UT, USA) using 1 ml( ,1.8 mL of throat swab) of extracted DNA in
10 ml of TaqMan Universal PCR Master Mix (Roche), containing
5 mM MgCl2 and 400 nM forward and reverse primers. Reaction
conditions were as follows: initial denaturation at 95uC for 15 min,
followed by 45 cycles of denaturation at 95uC for 1 s, annealing at
60uC for 15 s, and extension at 72uC for 5 s. The progress of real-
time fluorescent PCR was monitored at 530 nm. To establish
external standard curves for the quantification of HAdV-14,
genomic DNA from the prototype de Wit strain (HAdV-14p) were
diluted in a 10-fold series (10
2 to 10
7 copies per reaction) and
analyzed with the new assay. The samples that defined the standard
curve were performed in triplicate. The crossing point (CP) for 10
7
was 17.4 and the CP for 100 copies was 37.3. Triplicate samples
were used to generate standard curve experiments. Standard curves
were repeated twice and we saw similar results. Samples were
considered positive if they had a crossing point less than 40 (Fig. 1).
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